YOUR SAMPLES ARE PRECIOUS, SO WE TREAT THEM
AS OUR OWN
Worldwide’s Bioanalytical Lab has been in the business of analyzing samples for 3 decades. What makes us difference from other CROs? We focus on excellence and providing high quality data. That’s it. You won’t be passed around the team. You won’t get lost in the shuffle. We know your samples are valuable, so we apply the golden rule: we treat them like our own.
And we don’t just make these claims – we’ve been recognized by our customers for putting our words into action.
Worldwide has a wealth of experience analyzing both innovator and generic drugs. With over 2,400 validated assays, we have experience with a variety of matrices (plasma, serum, blood, cerebrospinal fluid (CSF), urine, etc.) from all types of species (human, dog, rat, monkey, pig, etc.). With this breadth of knowledge, your program gets the best, high-quality attention from analysts with years of experience. Best of all, we continuously measure KPIs and conduct trend analysis. We don’t settle for less than the best, and that’s why we’re referred to as the “uncommon CRO.”
QUALITY PROFESSIONALS THAT YOU CAN COUNT ON
Our failure rate is well below the industry average of 5%. This is one of the reasons we’re uncommon – and one of the reasons Worldwide was awarded as a top-performer for its Phase I services, according to the 2019 CRO Quality Benchmarking – Phase I Service Providers Report.
We invest heavily in automation to minimize assay variability and eradicate errors. Worldwide’s robust training program requires each analyst to qualify on an assay before touching your samples. When the success of your drug program rides on the results of your sample, work with a CRO that takes special care to provide the highest quality results.
HIGH REGULATORY STANDARDS ARE NON-NEGOTIABLE
For regulated studies, our bioanalytical facility adheres to Good Laboratory Practice (GLP) regulations for preclinical samples and Good Clinical Practice (GCP) regulations for clinical samples. Our methods are validated to Food and Drug Administration (FDA), European Medicines Agency (EMA), and ICH M10 standards. We can also accommodate early discovery sample analysis.
CUTTING-EDGE EQUIPMENT FOR YOUR SUCCESS
You spoke, we listened. We know that access to unique tests, machines, and equipment is a key factor in CRO selection. Our commitment to our clients is to stay at the forefront of technology, providing the fastest, most accurate results possible. We were among the highest-ranking CROs in the latest CRO Quality Benchmark Report for our equipment accessibility, which includes:
- 21 Sciex LC-MS/MS systems
- 10 API 4000
- 10 API 5000
- 1 QTRAP 6500
- State-of-the-art LC systems
- 5 Waters Acquity UPLC
- 10 Shimadzu Nexera SIL-30 UPLC
- 11 CTC DLW PAL Autosamplers
- Automated liquid handling systems
- 4 Hamilton STAR and STARlet
- 5 Tomtec Quadra 4 SPE
- 1 Tecan Genesis
READY TO TALK ABOUT YOUR PRECLINICAL AND CLINICAL SAMPLE ANALYSIS NEEDS?
We believe in trust, communication, and leadership. When your early phase development program needs quick, nimble, quality support – look no further than Worldwide Clinical Trials.